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Background: Because in vitro blood–brain barrier (BBB) models are important tools for studying brain diseases and
drug development, we recently established a new line of conditionally immortalized human brain microvascular
endothelial cells (HBMEC/ciβ) for use in such models. Since one of the most important functional features of the
BBB is its strong intercellular adhesion, in this study, we aimed at improving HBMEC/ciβ barrier properties by means
of culture media modifications, thus enhancing their use for future BBB studies. In addition, we simultaneously
attempted to obtain insights on related mechanistic properties.
Methods: Several types of culture media were prepared in an effort to identify the medium most suitable for culturing
HBMEC/ciβ. The barrier properties of HBMEC/ciβ were examined by determining Na+-fluorescein permeability and
transendothelial electric resistance (TEER). Endothelial marker mRNA expression levels were determined by quantitative
real-time polymerase chain reaction. Adherens junction (AJ) formation was examined by immunocytochemistry.
Cell migration ability was analyzed by scratch assay. Furthermore, cellular lipid composition was examined by liquid
chromatography-time-of-flight mass spectrometry.
Results: Our initial screening tests showed that addition of hydrocortisone (HC) to the basal medium significantly
reduced the Na+-fluorescein permeability and increased the TEER of HBMEC/ciβ monolayers. It was also found
that, while AJ proteins were diffused in the cytoplasm of HBMEC/ciβ cultured without HC, those expressed in cells
cultured with HC were primarily localized at the cell border. Furthermore, this facilitation of AJ formation by HC
was in concert with increased endothelial marker mRNA levels and increased ether-type phosphatidylethanolamine
levels, while cell migration was retarded in the presence of HC.
Conclusions: Our results show that HC supplementation to the basal medium significantly enhances the barrier
properties of HBMEC/ciβ. This was associated with a marked phenotypic alteration in HBMEC/ciβ through
orchestration of various signaling pathways. Taken together, it appears that overall effects of HC on HBMEC/ciβ
could be summarized as facilitating endothelial differentiation characteristics while concurrently retarding
mesenchymal characteristics.
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The blood–brain barrier (BBB), which is formed primar-
ily by brain microvascular endothelial cells (BMECs), is
an interface between the central nervous system (CNS)
and the systemic circulation [1]. Several cell types
located adjacent to BMECs (including astrocytes and
pericytes) are also known to contribute to BBB function.
One of the most important features of the BBB is its
extremely strong intercellular adhesion, which is estab-
lished by adherens junctions (AJs) and tight junctions
(TJs) between the endothelial cells [1]. This forceful
adhesion seals the paracellular route and prevents entry
of a variety of substances, both small and large, into
brain from blood, while simultaneously creating a foun-
dation that allows BMEC transporters to take up or
expel molecules indispensable for, or harmful to, the
physiological functions of the brain.
Based on this functional importance in maintaining
brain homeostasis, it has become increasingly evident
that impairment of BBB function is associated with vari-
ous CNS diseases, such as multiple sclerosis, amyo-
trophic lateral sclerosis and Alzheimer’s disease, even
though it remains currently inconclusive whether BBB
impairment is a cause or consequence of those diseases
[2,3]. On the other hand, because the BBB appears to
prevent passage of more than 98% of all small thera-
peutic molecules [4], the barrier is considered a primary
obstacle that prevents drugs from exercising their
pharmacological actions in brain. This is a critical reason
why the development of CNS drugs is difficult and time
consuming. Collectively, the BBB is a pivotal research
target for various brain diseases and CNS drug develop-
ment studies.
In vitro BBB models are among the most important
tools used in BBB studies [5,6]. While it is probably
inevitable that in vitro BBB models will never reflect the
full range of in vivo BBB functionalities due to their
differing environments, such models offer multiple ex-
perimental benefits in terms of simplicity, scalability,
and versatility. In in vitro BBB models, BMECs are
cultured on a porous membrane in a transwell culture
system, thereby resulting in a cell layer that creates
separate blood-side and brain-side compartments. To
date, human and animal primary BMECs, as well as
immortalized human and animal BMECs, have been
extensively utilized in such models [6]. The primary cells
show excellent functionality, but they suffer from several
experimental limitations, such as scarcity, low cell prolif-
eration potential and sample to sample variations. On
the other hand, even though the functional levels of
immortalized cells are not regarded as being as high as
that of the freshly isolated primary cells, they show infin-
ite proliferation ability and stable phenotypes, which
makes them useful to researchers conducting a variety ofexperiments. Therefore, it would be ideal if, through the
refinement and elaboration of their culture methods, the
BBB functions of immortalized cells could be improved
to levels that are comparable to primary cells.
Recently, we reported establishment of a new line of hu-
man immortalized BMECs, HBMEC/ciβ [7]. In addition
to excellent proliferative ability, HBMEC/ciβ express a
series of endothelial marker genes (e.g., von Willebrand
factor (vWF) and vascular endothelial-cadherin (VE-
cadherin)) along with BBB-related genes (e.g., claudin-5,
glucose transporter 1, P-glycoprotein, and transferrin
receptor), and limited sucrose and Na+-fluorescein (Na-F)
penetration across cell monolayers. Based on these charac-
teristics, it is logical to conjecture that HBMEC/ciβ have
significant potential for providing the foundation of
uniquely effective in vitro BBB models. However, to
achieve this goal, further improvements to the intercel-
lular junctional property of the cells are absolutely
necessary.
Since it is well known that the barrier function of
in vitro BBB models can be reinforced or degraded by
various biological and chemical factors [6], it is also
likely that the culture media composition plays a crucial
role in determining the strength of the HBMEC/ciβ
barrier function. In this regard, it was noted that the
culture medium we used initially was designed for
pan-primary cells, which caused us to consider the pos-
sibility that media optimization for HBMEC/ciβ culture
might enhance barrier properties. Accordingly, the pri-
mary purpose of the present study was to clarify the
effects of culture media modifications on HBMEC/ciβ
barrier functions. In addition, we provide results that




CSC medium (Complete Medium Kit containing 10%
fetal bovine serum, 4Z0-500-R, Cell Systems, Kirkland,
WA, USA) or EBM2 medium (Lonza, Walkersville, MD,
USA) was used as a basal medium. CultureBoost-R (cbR,
2% v/v, Cell Systems) and SingleQuots (SQs, Lonza)
were used as culture supplements. Although the compo-
nents of cbR are not published, according to the manu-
facturer’s information it contains several growth factors.
SQs consist of a series of vials, each of which contains
2% (v/v) fetal bovine serum, 0.1% (v/v) vascular endothe-
lial growth factor, 0.1% (v/v) long R3 insulin-like growth
factor, 0.1% (v/v) recombinant human epidermal growth
factor, 0.4% (v/v) recombinant human basic fibroblast
growth factor, 0.1% (v/v) hydrocortisone (HC), 0.1% (v/v)
heparin or 0.1% (v/v) ascorbate. The actual HC concen-
tration is 180 nM based on our determination using
enzyme-linked immunosorbent assay. Additionally, all
Furihata et al. Fluids and Barriers of the CNS  (2015) 12:7 Page 3 of 15culture media were supplemented with blastcidin S
(4 μg/mL) and penicillin-streptomycin. Medium infor-
mation is also provided in Additional file 1: Figure S1.
Cell culture
HBMEC/ciβ were routinely grown on type-I collagen-
coated dishes in CSC-cbR at 33°C with 5% CO2/95% air.
They were seeded (day 0) at 1.0 × 105 or 4.0 × 105 cells/
mL onto a dish or a membrane filter of an insert culture
system (polyethylene terephthalate, 0.4 μm high-density
pores, and 0.3 cm2, BD Falcon, Franklin Lakes, NJ,
USA), respectively. At day three, the medium was chan-
ged to either the same or a differently supplemented
medium, depending on the experiments (for example,
the medium was changed from CSC-cbR to CSC-HC at
day three). Then, the cells were continuously cultured
for 12 days, during which a medium change was con-
ducted every other day. All functional or gene expres-
sion analyses were performed on day 12. The culture
schedule is also provided in Additional file 1: Figure S1.
Permeability assay
The apparent permeability (Papp, cm/min) and the per-
meability coefficients (Pe, cm/min) of Na-F (Sigma, St.
Louis, MO, USA) and [14C] sucrose (GE Healthcare, Giles,
UK) were determined essentially as described previously
[7]. Briefly, the medium was replaced with serum-free
CSC medium 30 min before the assay (4Z3-500-R, Cell
Systems). The assay was initiated by adding [14C] sucrose
(0.1 μCi/mL) or Na-F (500 ng/mL) to the insert at 37°C.
The incubation time was 40 min. The Pe values were
calculated using the permeability-surface area product
(PS, μL/min) described in our previous report [7], and
the Papp values were calculated using the following
equation:
Papp cm=minð Þ ¼ Vbaso cm
3ð Þ
A cm2ð Þ  C0½ api ng=μLÞð
 Δ C½ baso ðng=μLÞ
ΔT minð Þ
where Vbaso is medium volume at the basolateral side, A
is membrane surface area (0.3 cm2), [C0]api is Na-F con-
centration at the apical side at T = 0, [C0]baso is Na-F
concentration at the basolateral side at T = 40, and ΔT is
time of experiment.
Determination of transendothelial electric resistance
(TEER)
TEER was examined using the Millicell ERS-2 (Milli-
pore, Billerica, MA, USA) before performing permeabil-
ity analysis. After subtracting the ohms of a blank insert
membrane from the ohms of cell monolayer, the value
was multiplied by 0.33 cm2 (Ω × cm2).Total RNA isolation, cDNA synthesis, and quantitative
real-time polymerase chain reaction (qPCR)
Total RNA extraction and cDNA synthesis of the
HBMEC/ciβ (cultured as described above) were con-
ducted using methods described previously [7]. qPCR
was performed using the previously-described SYBR
green-based method [7] to determine the following
mRNA expression levels: glucocorticoid-induced leu-
cine zipper (GILZ), nuclear factor-Kappa B inhibitor
alpha (NFκBIA), annexin A1 (ANXA1), matrix metal-
loproteinase 1 (MMP-1), MMP-2, MMP-16, vWF, Duffy
antigen/receptor for chemokines (DARC), angiopoietin 2
(ANGPT2), early growth response 1 (EGR-1), histone dea-
cetylase 7 (HDAC7), inhibitor of differentiation or DNA
binding-1 (Id-1), Ras-proximate-1 or Ras-related protein 1
(RAP1), exchange protein directly activated by cAMP
(EPAC), VE-cadherin, claudin-5, occludin, glycerone-
phosphate O-acyltransferase (GNPAT), alkylglycerone-
phosphate synthase (AGPS), fatty acyl-CoA reductase 1
(FAR1), and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). The primers used for qPCR are described in
(see Additional file 2: Table S1), and the amplification
efficiency of each PCR was confirmed to be close to one.
Data was calculated using the delta-delta-CT method,
where GAPDH was used as a control.
Western blotting analysis
HBMEC/ciβ cells were cultured on dishes as described
above. Homogenates were prepared using methods
described previously [7]. Proteins were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis, and then transferred onto a polyvinyldene difluoride
membrane. The membrane was blocked with 5% skim
milk. The primary antibodies used were rabbit anti-
glucocorticoid receptor (GR) polyclonal IgG (1,000-fold
dilution, sc-1002, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), rabbit anti-VE-cadherin polyclonal IgG
(1,000-fold dilution, sc-28644, Santa Cruz Biotechnol-
ogy), rabbit anti-claudin-5 polyclonal IgG (1,000-fold
dilution, ab53765, Abcam, Cambridge, UK), or rabbit
anti-occludin polyclonal IgG (1,000-fold dilution, 71–
1500, Zymed Laboratories, San Francisco, CA, USA).
The secondary antibody used was goat anti-rabbit IgG–
peroxidase antibody (10,000-fold dilution, A9196, Sigma).
Fluorescence detection of adherens junction-related
proteins
The insert membrane filter on which HBMEC/ciβ were
cultured was taken out, followed by incubation with BD
Cytofix/Cytoperm Fixation and Permeabilization Solu-
tion (BD Biosciences) for 40 min at 4°C (fixation). The
membrane was then incubated with BD Perm/Wash
Buffer (BD Biosciences) for 15 min at room temperature
(permeation), and blocked with BLOCKACE (DS Pharma
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cytochemistry, the primary antibodies used were anti-
VE-cadherin rabbit polyclonal IgG (100-fold dilution,
sc-28644, Santa Cruz Biotechnology), anti-β-catenin
rabbit monoclonal IgG (100-fold dilution, #8480, Cell
Signaling Technology, Danvers, MA, USA), and anti-
zonula occludens-1 (ZO-1) rabbit polyclonal IgG (100-fold
dilution, #5406S, Cell Signaling Technology). The second-
ary antibodies used were Rhodamine (TRITC)-AffiniPure
F(ab’)2 Fragment goat anti-rabbit IgG (100-fold dilution,
Jackson Immuno Research Laboratories, West Grove,
PA, USA) or Alexa Fluor 488 donkey anti-rabbit IgG
(100-fold dilution, Life Technologies). The above anti-
bodies were diluted to the indicated concentrations with
CanGetSignal immunostain solution A (TOYOBO, Osaka,
Japan). It was confirmed that the secondary antibodies did
not bind to cellular proteins in a non-specific manner. For
F-actin detection, the membrane was incubated with
Acti-stain 488 Fluorescent Phalloidin (150-fold dilution,
Cytoskeleton, Denver, CO, USA) for 30 min at room
temperature. Fluorescence was detected using the OLYM-
PUS LSM (Olympus, Tokyo, Japan). The above im-
munocytochemical analyses were also performed in the
presence of GGTI298 (5 μM, Sigma), a RAP inhibitor.
The inhibitor or its vehicle (DMSO) was added during
every medium change (Days 3, 5, 7, 9 and 11).
Scratch assay
HBMEC/ciβ cells were cultured on dishes as described
above. A scratch on the cell monolayer was created
using a tip, immediately after which the medium was
changed to wash away the floating cells (time = 0). Cell
migration status was observed at time = 0, 6, and 12 hrs.
The width of the scratch was calculated using Motic
Image Plus 2.2S (Shimadzu, Tokyo, Japan).
Lipidomics analysis
HBMEC/ciβ cells were cultured on dishes with CSC-free
or CSC-HC. The cells were also cultured with CSC-HC
containing RU486. After twelve days of culturing (at the
confluent status), cells were washed twice with phos-
phate buffered saline (PBS), and collected. Lipids, corre-
sponding to half of one dish, were extracted from the
cells with 200 μL of methanol with internal standards
(2 μM of 12:0/12:0 phosphatidylcholine (PC) [Avanti
Polar Lipids, Alabaster, AL, USA] for PC, 2 μM of 12:0/
12:0 phosphatidylethanolamine (PE) [Avanti Polar Lipids]
for PE and 0.5 μM of d18:1/17:0 sphingomyelin (SM)
[Avanti Polar Lipids] for SM). Next, filtering was per-
formed for the following non-targeted measurement of
PC, ether-type PC (ePC), PE, ether-type PE (ePE), and SM
by liquid chromatography-time-of-flight mass spectrom-
etry (LC-TOFMS; ACQUITY UPLC System [Waters,
Milford]-LCT Premier XE [Waters, Milford]), as describedpreviously [8]. The relative standard deviation of the in-
ternal standards (PC, PE and SM), which monitor experi-
mental quality throughout extraction and measurement,
were 5.6%, 7.9% and 9.7%, respectively.
Raw data obtained by LC-TOFMS were processed
using 2DICAL software (Mitsui Knowledge Industry,
Tokyo, Japan), which allows detection and alignment of
the ion peaks of each ionized biomolecule obtained at
the specific m/z and column retention time (RT). The
main 2DICAL parameter was set as described previ-
ously with a few modifications [8]. The RT range was
set from 2.0 to 38.0 min in the negative ion mode in
order to extract the ion peaks. Ion peaks with the top
300 signal intensities were set as the cut-off and were
used in the following data analyses. Extracted ion peaks
were subjected to identification of lipid molecules by
comparison of ion features, including RT, m/z, preferred
adducts, and in-source fragments, of the experimental
samples with those of our reference library of lipid mol-
ecule entries, as described previously [8]. Processing of
extracted ion peaks yielded 104 lipid molecules, including
40 PC, 7 ePC, 26 PE, 21 ePE and 10 SM (see Additional
file 3: Table S2). To determine the amount of each lipid
molecule, the intensities of each extracted ion peak were
normalized to those of the internal standards.
Statistical analysis
One-way analysis of variance was first performed to
determine whether there was a significant difference
among values, after which a Student’s t-test was per-
formed to determine statistical significance of difference
between values. A statistical software package (Statcell,
OMS, Saitama, Japan) was used for these analyses.
Results
Culture media composition differentially affected junctional
properties of HBMEC/ciβ
Several media that have been optimized for endothelial
cell culture are currently commercially available. Taking
advantage of the successful use of these media in endo-
thelial cell culture, we conducted preliminary screenings
to identify the medium most suitable for HBMEC/ciβ
culture. Although the results are not shown here, it was
determined that, among the media, the EBM basal 2
medium supplemented with SingleQuots (EBM2-SQs)
provided differential effects on the morphology and gene
expression profile of HBMEC/ciβ when compared to
those cultured with our initially-used medium, which was
a CSC-complete recombinant serum-containing medium
supplemented with cbR (CSC-cbR). (Please note that
medium is called “basal medium-supplement” throughout
the manuscript.)
We then proceeded to examine the effects of different
combinations of basal media and culture supplements
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Na-F permeability to determine whether either EBM-2
and SQs or both would affect HBMEC/ciβ barrier prop-
erties (Figure 1). The results showed that neither EBM2-
cbR nor EBM2-SQs improved the junctional properties
of HBMEC/ciβ over the levels obtained using CSC-cbR.
However, CSC-SQs significantly decreased the Na-F
permeability of HBMEC/ciβ. Therefore, it appeared that
SQs was effective in strengthening the barrier property
of HBMEC/ciβ, while the CSC basal medium was also
essential.
Hydrocortisone was identified as a component of SQs
responsible for improving HBMEC/ciβ barrier properties
It was expected that improvements in HBMEC/ciβ barrier
properties by CSC-SQs culture conditions would be due
to either the withdrawal of cbR from or the addition of
SQs to the CSC basal medium. To clarify which was
responsible, we first compared barrier properties of cells
cultured with CSC-cbR to those cultured with CSC
basal medium alone (CSC-free). The results showed the
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Figure 1 Effects of different basal medium and supplement
combinations on Na-F permeability in HBMEC/ciβ-based
blood–brain barrier model. Four media types were prepared,
where either CSC or EBM2 basal medium (indicated by “Basal”) was
supplemented by either cbR or SQs (indicated by “Suppl”). Three
days after cell seeding, the initial medium was changed to one of
the above-mentioned media. The cells were cultured continuously
for 12 days, after which permeability assay was performed. Na-F
permeability (Papp, × 10
−3 cm/min) was expressed as mean ± S.D.
of three independent experiments. The asterisk indicates p < 0.05
compared to the value of CSC-cbR.(Figure 2A), thus suggesting that SQs were likely to play
the primary improvement role in the HBMEC/ciβ
barrier property.
SQs consists of several culture support agents. To
identify the primary component(s) of SQs that was re-
sponsible for favorable effects on HBMEC/ciβ barrier
properties, individual factors were examined separately
(Figure 2B). Among those factors, HC alone (180 nM)
was found to be effective in strengthening HBMEC/ciβ
barrier function. The Na-F Papp value of the cells cul-
tured with CSC-HC was 0.71 ± 0.10 (×10−3 cm/min),
which was significantly lower than that of CSC-cbR
(1.46 ± 0.15 [×10−3 cm/min]). Next, the cooperative ac-
tions of cbR or other SQ factor(s) with HC on barrier
tightening were tested. However, no combination showed
effects that were superior to that of HC alone (Figure 2C
and see Additional file 4: Figure S2).
To further verify the barrier-strengthening effect of
HC, Na-F and sucrose Pe values, along with TEER, were
determined. Results showed that Na-F and sucrose Pe
values of cells cultured with CSC-HC were less than
40% of those cultured with CSC-cbR (Figure 2D), and
that TEER values were more than 10-fold higher in cells
cultured with CSC-HC compared with that of CSC-cbR
(Figure 2E). Taken together, the results showed that HC
was a primary component in the SQs that could enhance
the HBMEC/ciβ barrier function.Glucocorticoid receptor was involved in hydrocortisone-
mediated functional improvements in HBMEC/ciβ barrier
properties
It is well known that HC is a ligand of the nuclear recep-
tor, GR, and that binding of HC to GR stimulates its
translocation to the nucleus, where GR modulates gene
expression [9]. This is considered to be the primary
pathway via which HC elicits pleiotropic effects on cellular
function. To clarify the involvement of GR in HC-
mediated improvements in HBMEC/ciβ barrier properties,
the functional expression of GR was first characterized.
Western blotting analysis showed that GR protein expres-
sion was clearly detected in HBMEC/ciβ (Figure 3A). In
addition, qPCR showed that mRNA levels of known GR-
target genes, GILZ [10], NFκBIA [11,12], and ANXA1
[13,14], were significantly increased in HC-containing
medium (Figure 3B). Furthermore, increased mRNA ex-
pression of these genes was prevented by addition of
RU486 (250 nM), a GR-antagonist. Given this clarification
of functional GR expression in HBMEC/ciβ, the effects of
RU486 on the Na-F permeability and TEER of these
cells were examined. RU486 treatment nullified the
barrier-tightening effects of HC (Figure 3C). These results
indicate that GR plays a crucial role in HC-mediated im-



































































































































Figure 2 Identification and characterization of barrier strengthening effects of hydrocortisone on HBMEC/ciβ-based blood–brain
barrier model. (A) The effect of cbR withdrawal from the culture medium on HBMEC/ciβ barrier properties was examined. The “-” symbol
indicates the absence of cbR. (B) SQs components were screened for identification of the factors responsible for barrier property improvement.
Here, the “-” symbol indicates the absence of growth factors. (C) The effect of cbR on the HC-mediated decrease in Na-F permeability of HBMEC/
ciβ was examined. Here, the “-” symbol indicates the absence of HC. (D) The effect of HC on barrier function of HBMEC/ciβ was confirmed by
determining the relative Pe values of Na-F (left) and sucrose (right) permeability. The value obtained from the cells cultured with CSC-HC was
calculated relative to the value obtained from CSC-cbR cells (set as basal level =1) in each assay. (E) TEER was examined and compared between
HBMEC/ciβ cultured with CSC-cbR and CSC-HC. The values of Na-F permeability (Papp or Pe) (×10−3 cm/min) and TEER (Ω × cm2) were expressed
as mean ± S.D. of three independent experiments. The single, double, and triple asterisks indicate p < 0.05, p < 0.01, and p < 0.005, respectively,
compared to the value of CSC-SQs in (B) or CSC-cbR in (D) and (E).
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hydrocortisone
To further clarify the mechanisms underlying the barrier-
strengthening effect of HC, the status of intercellular junc-
tion formation in HBMEC/ciβ cultured with each medium
was examined by immunocytochemistry for VE-cadherin
and β-catenin, which are representative components of AJ
[15], and ZO-1, which is an important molecule for both
AJ and TJ [16,17] (Figure 4). The results showed that
VE-cadherin, β-catenin and ZO-1 were localized at the
cell-to-cell border membrane in cells cultured with CSC-
HC, while they primarily diffused throughout the cyto-
plasm in cells cultured with CSC-cbR and CSC-free. The
plasma membrane localization in cells cultured with CSC-
HC was significantly impaired by RU486 treatment.
In addition, the intracellular organization of F-actin
was determined using fluorescently labeled phalloidin,because it has been known that F-actin undergoes
structural remodeling to localize to the peri-plasma
membrane region, where it can stabilize AJ [18]. The
results of phalloidin-staining showed that F-actin ap-
peared concentrated in the vicinity of the plasma mem-
brane in cells cultured with CSC-HC, but not in those
cultured with other media. Similar to the junctional
proteins, this circumferential organization was severely
disrupted by RU486 treatment. Because it was also
possible that HC enhanced VE-cadherin expression in
HBMEC/ciβ, qPCR and Western blotting analyses were
performed. However, no increase in VE-cadherin mRNA
or protein was observed with HC (see Additional file 5:
Figure S3).
Tight junctions play a crucial role in BBB function
[1,19], therefore, qPCR and Western blot analyses were



























































































































































Figure 3 Involvement of glucocorticoid receptor in the effects of hydrocortisone on HBMEC/ciβ barrier function. (A) GR protein
expression was examined by Western blot analysis. The arrowhead indicates 100 kDa. (B) mRNA expression level of representative GR-target
genes (ANXA1, GILZ, and NFκBIA) in cells cultured with CSC-cbR, CSC-free, or CSC-HC were examined by qPCR. Effect of a GR antagonist, RU486
(RU), on HC-mediated induction of mRNA expression was also investigated. mRNA expression levels were calculated relative to the value obtained
from CSC-cbR cells (set as the basal level =1). (C) Effects of RU486 on HC-mediated barrier reinforcement was examined by determining Na-F permeability
(left) and TEER (right). Each value in the above experiments is expressed as mean ± S.D. obtained from three independent experiments. In (B) and (C), the
“-” symbol indicates DMSO (0.1%) was added to the medium as a control. The single and double asterisks indicate p< 0.05 and p < 0.01, respectively,
compared to the value of CSC-free in (B) or CSC-cbR in (C).
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or occludin protein expression levels were observed in
the presence of HC, even though occludin mRNA levels
were increased (see Additional file 6: Figure S4). Next,
immunocytochemical analyses of claudin-5 and occludin
were performed. However, those analyses showed that
they were not clearly identified at the cell border, thus
indicating tight junction immaturity (data not shown).
These results suggested that facilitation of AJ formation
in HBMEC/ciβ was likely related to barrier function
improvements by HC.
The EPAC-RAP1 pathway is involved in hydrocortisone-
mediated facilitation of adherens junction formation in
HBMEC/ciβ
The HC-mediated facilitation of AJ formation described
above is reminiscent of findings that show the EPAC-
RAP1 pathway plays a pivotal role in AJ formation by
recruiting AJ proteins to the plasma membrane [21].
Thus, to explore the relationship between these twoevents, the effect of GGTI298 (a RAP1 inhibitor) on the
actions of HC in HBMEC/ciβ was examined. Results
showed that in GGTI298-treated cells, VE-cadherin, β-
catenin, and ZO-1 were dispersed intracellularly, which
clearly differs from their cellular localization profiles
in cells with CSC-HC (Figure 5A). Consistently, the
lowered Na-F permeability with HC was completely re-
versed in the presence of GGTI298 (results not shown).
Therefore, inhibition of RAP1 activity appears to abro-
gate the actions of HC.
An interplay between the EPAC-RAP1 and HC signaling
pathways was also identified by real-time PCR analyses
(Figure 5B). EPAC and RAP1 mRNA levels were, respect-
ively, 3.7-fold and 2.5-fold higher in HBMEC/ciβ cultured
with CSC-HC than in CSC-free cultures. In addition,
enhanced EPAC and RAP1 mRNA levels were not ob-
served in CSC-HC cells when RU486 was present.
These results suggest that the EPAC-RAP1 pathway
plays a critical role in HC-mediated facilitation of AJ
formation in HBMEC/ciβ.
Figure 4 Immunocytochemical analysis of adherens junction proteins and the effect of hydrocortisone. Immunocytochemistry was
performed to identify the cellular localization of VE-cadherin, β-catenin, and ZO-1 in cells cultured with CSC-cbR, CSC-free, or CSC-HC. Phalloidin
staining was performed to analyze F-actin distribution. The effect of RU486 on the distribution of the junction-related proteins was also investigated in
cells cultured with CSC-HC. The experiments were repeated six times, and representative results are shown: “+” or “-” symbols indicate the addition of
RU486 or DMSO (0.1%) to the medium, respectively.
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hydrocortisone
Proper AJ formation is generally associated with endo-
thelial cell differentiation [15,22]. When cell morphology
was examined during the above experiments, it was found
that cells cultured with CSC-HC showed more spindle-
like shapes with overall streamline contours, compared
with cells cultured with other media (Figure 6A). However,
this was not observed in the presence of RU486. Subse-
quently, the mRNA expression levels of endothelial
differentiation marker genes vWF and DARC were ana-
lyzed (Figure 6B). The mRNA levels for both genes were
significantly higher in CSC-HC cells than in those with
other media. Thus, it appears that the endothelial cell
differentiation of HBMEC/ciβ was promoted by HC
through a GR pathway.
HBMEC/ciβmigration ability was retarded by hydrocortisone
It is known that endothelial cells reduce their growth activ-
ity and motility upon establishment of intercellular junc-
tions [15]. Therefore, the migration ability of HBMEC/ciβ
was examined by the scratch assay (Figure 7). The results
showed that, as expected, the migration ability of the
cells was retarded in the absence of cbR. Furthermore, it
was found that addition of HC to the medium resulted
in a further significant reduction in cell migration. Theeffects of HC were completely negated by RU486 treat-
ment. Therefore, these results showed that cell migra-
tion was inhibited by HC via the GR function.
A key contributor to cell motility is the family of
MMPs that is capable of degrading the extracellular
matrix in order to facilitate cell migration [23,24]. Thus,
we hypothesized that the differential cell migration
shown in Figure 7 would be associated with altered
MMP expression. Since our preliminary microarray ana-
lysis had shown that, among the family members, MMP-
1, MMP-2, and MMP-16 expressions were detected in
HBMEC/ciβ (data not shown), the mRNA expression
levels of these MMPs were examined in cells cultured
with each medium (Figure 8). The results showed that
cbR withdrawal from the medium caused more than
350-fold and 2-fold decrease in MMP-1 and MMP-16
mRNA levels, respectively, while it also led to more than
16-fold increase in MMP-2 mRNA levels. This might, at
least partially, explain less significant reduction of migra-
tion ability observed in cells cultured with CSC-free
conditions compared with those cultured in CSC-cbR.
In addition, the results showed that HC treatment
significantly reversed MMP-2 mRNA levels and further
reduced MMP-16 mRNA levels (by 3.2-fold and 2.8-fold,
respectively), while maintaining the repressive status of
MMP-1 expression (Figure 8). Again, the effects of HC
Figure 5 Impairment of hydrocortisone-mediated facilitation of adherens junction formation by inhibiting RAP1 activity. (A)
Immunocytochemistry was performed to examine the cellular localization of VE-cadherin, β-catenin, and ZO-1 in cells cultured with CSC-HC in
the presence or absence of a RAP1 inhibitor, GGTI298 (5 μM). Phalloidin staining was performed to analyze F-actin distribution. The experiments
were repeated three times and representative results are shown. The “+” or “-” symbols indicate the addition of GGTI298 or DMSO (0.1%) to the
medium, respectively. (B) EPAC and RAP1 mRNA expression levels in cells cultured with CSC-free or CSC-HC were examined by qPCR. Effect of
RU486 on HC-mediated induction of mRNA expression was also investigated. mRNA expression levels were calculated relative to the value obtained
from CSC-free cells (set as the basal level =1). Each value is expressed as mean ± S.D. obtained from three independent experiments. The single and
double asterisks indicate represent p < 0.05 and p < 0.01 respectively, relative to CSC-free.
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apparently consistent with the minimum migration
ability of HBMEC/ciβ cultured with CSC-HC among
the conditions, suggesting that altered MMP expression
levels were involved in the effects of HC on HBMEC/
ciβ mortality.
Ether-type phosphatidylethanolamine levels were affected
by hydrocortisone
Since the morphology and mobility of HBMEC/ciβ dif-
fered significantly depending on the presence and ab-
sence of HC, it was speculated that HC may actively
influence the membrane lipid composition necessary to
adapt to global cellular phenotypic alterations. Thus, a
lipidomics approach, primarily focusing on major mem-
brane lipid molecules (glycerophospholipids and sphingo-
myelin), was utilized in order to determine whether lipid
composition differed among cells cultured with CSC-free,CSC-HC, or CSC-HC with RU486. While PC, ePC, PE,
and SM levels were not significantly different among the
conditions, ePE level in cells with CSC-HC was increased
to a slight, but significant, degree compared to CSC-free
(Figure 9A). Furthermore, this increase was mostly re-
versed by RU486 treatment.
Based on those results, detailed ePE molecule deter-
mination was conducted in order to identify the ePE
species primarily affected by HC. The results showed
that, among twenty-one molecules showing effective signal
intensities, five molecules (38:5ePE, 36:5ePE, 38:7ePE,
37:5ePE, and 36:3ePE) were significantly increased in cells
cultured with CSC-HC compared to CSC-free (Figure 9B).
Furthermore, 38:5ePE and 36:5ePE were found to be the
primary ePE species among the five (Figure 9B). It has pre-
viously been known that these lipid molecules have the 1-
O-(1Z-alkenyl)-2-acyl-sn-glycerophosphatidylethanolamine




























































Figure 6 Promotion of endothelial cell differentiation of HBMEC/ciβ by hydrocortisone. (A) Cell morphology of HBMEC/ciβ cultured with
CSC-cbR, CSC-free, or CSC-HC was analyzed by microscopy. The effect of RU486 on cell morphology was also tested using cells cultured with CSC-HC. The
experiments were repeated four times and representative results are shown. (B)mRNA expression levels of representative endothelial cell differentiation
marker genes (vWF and DARC) were determined by qPCR and calculated relative to the value obtained from CSC-cbR cells (set as basal level = 1).
The “+” or “-” symbols indicate addition of RU486 or DMSO (0.1%) to the medium, respectively. Each value is expressed as mean ± S.D. obtained from three
































Figure 7 Retardation of HBMEC/ciβ migration by hydrocortisone. Migration abilities of HBMEC/ciβ cultured with CSC-cbR, CSC-free, or CSC-HC
were examined by scratch assay. The effect of RU486 on cell morphology was also tested using cells cultured with CSC-HC. Wound width was
determined under microscopic observation at 0, 6 and 12 hours after the scratch had been made. The experiments were repeated three times
and the representative results are shown. In the right side, the relative value of wound width was calculated as the value obtained at time 0
(immediately after scratch) was set to 1, and each value is expressed as mean ± S.D. obtained from three independent experiments. The asterisk
indicates p < 0.05 compared to the value of CSC-free.












































































Figure 8 Matrix metalloproteinase mRNA expression profile in HBMEC/ciβ cultured with each medium. MMP-1, -2, and -16 mRNA
expression levels in cells cultured with CSC-cbR, CSC-free, or CSC-HC were examined by qPCR. The effect of a GR antagonist, RU486, on HC-mediated
modulation of mRNA expression was also investigated. The inset of the figure of MMP-1 shows magnified results obtained from cells cultured with
CSC-free and CSC-HC (in the absence or presence of RU486) (left, middle, and right bar, respectively). mRNA expression levels were calculated relative
to the value obtained from cells of CSC-cbR (set as basal level =1). Each value in the above experiments is expressed as mean ± S.D. obtained from
three independent experiments. The “-” symbol indicates that DMSO (0.1%) was added to the medium as a control. The asterisk indicates p < 0.05
compared to the value of CSC-free.
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38:5ePE and 36:5ePE were found to be primarily derived
from 18:0p/20:4 PE and 16:0p/20:4 PE, respectively.
Next, the effects of HC on mRNA levels of three key
ePE biosynthesis enzymes were examined. While FAR1
and AGPS mRNAs were not affected by HC, GNPAT
mRNA levels in cells cultured with CSC-HC were
significantly higher (over 3-fold) than cells cultured with
CSC-free (Figure 9C). This enhancement was not detected
in cells cultured with CSC-HC + RU486. Taken together,
these results showed that HC significantly modulated
cellular ePE levels, specifically 38:5ePE and 36:5ePE,
partially via enhancing GNPAT mRNA levels.
Discussion
Our results clearly show that culture media composition
indeed plays an important role in determining HBMEC/
ciβ functionality. Among the factors examined in this
study, the supplementation of HC to a medium at a
physiological concentration provides the highest benefi-
cial impact on the barrier functionality of the HBMEC/
ciβ-based in vitro BBB model. In addition to HC, our re-
sults showed that both the CSC basal medium and cbR
likely affect HBMEC/ciβ biology. However, since details
of cbR and CSC basal media composition have not been
published and since neither was capable of inducing a
notable functional improvement to the barrier property
of HBMEC/ciβ, the remainder of this discussion will
focus solely on the effects of HC.
HC-mediated enhancement of the HBMEC/ciβ barrier
function is consistent with previous results obtained
from porcine, mouse, rat, and human BMECs [25-28].The Na-F Papp of cells cultured with CSC-HC (0.71 [×10
−3
cm/min]) is comparable to that reported in rat or bovine
primary cell-based BBB models (0.92 and 0.66 [×10−3
cm/min]) [29,30]. The Na-F Papp is also close to those
obtained from other human-derived immortalized cell
lines (hBMEC, hCMEC/D3, and TY08), which are 0.30 to
0.75 (×10−3 cm/min) [31]. Therefore, even though the dif-
ferent experimental conditions employed among those
studies should be considered when interpreting their data,
it is believed that improvement of the HBMEC/ciβ barrier
function by HC significantly enhances their usability in
various BBB studies.
It has been acknowledged that AJs play an important
role in the control of vascular permeability [15,22], and
it is thus considered likely that the barrier tightening
effect of HC on HBMEC/ciβ is primarily mediated by
facilitating AJ formation. On the other hand, our results
also indicate immature TJ formation in the same culture
condition. Because both AJs and TJs are essential for
ensuring mature barrier integrity between cells through
their reciprocal interaction, it seems that a critical point
required for the achievement of further strengthening
barrier tightness of HBMEC/ciβ lies in facilitating TJ
formation. Since our present results are in accord with
the notion that AJ formation precedes TJ assembly
[22,32], the CSC-HC culture is presumed to provide
HBMEC/ciβ with a cellular foundation for TJ formation.
This indicates that additional stimuli that can be used to
build up firm TJs in the cells should be sought in future
experiments. These, if identified, can be expected to not
only further enhance HBMEC/ciβ functionality, but also





















































































































































Figure 9 Identification of unique ether-phosphatidylethanolamine increases in HBMEC/ciβ cultured with CSC-HC. (A) Total lipids were
extracted from cells cultured with CSC-free, CSC-HC or CSC-HC + RU486, and then subjected to LC-TOFMS analysis with a primary focus on the
major lipid molecules that make up cell membranes. Each lipid concentration was normalized with that of the internal standard, and each bar
represents a mean ± S.D. obtained from three independent experiments. (B) ePE concentrations were further determined using the same method.
Among the twenty-one ePE molecules showing effective signal intensity, the results of five molecules (38:5ePE, 36:5ePE, 38:7ePE, 37:5ePE, and
36:3ePE) are shown. The inset shows magnified results of three minor species. Each lipid concentration was normalized with that of internal standard,
and each bar represents a mean ± S.D. obtained from three independent experiments. (C) FAR1, GNPAT and AGPS mRNA expression levels in
cells cultured with CSC-free or CSC-HC were examined by qPCR. The effect of RU486 on the HC-mediated induction of mRNA expression was
also investigated. mRNA expression levels were calculated relative to the values obtained from CSC-free cells (set as the basal level =1). Values
are expressed as means ± S.D. obtained from three independent experiments. In all the above, single and double asterisks indicate p < 0.05 and
p < 0.01, compared to the CSC-free value.
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soluble factors, such as retinoic acid, cAMP, and hepato-
cyte growth factor, along with co-culture with astrocytes
and/or pericytes are capable of enhancing junctional
property of in vitro BBB models in an independent or
collaborative manner [28,33-35]. Therefore, it would be
worthwhile to test these culture modifications in order
to identify ways whereby TJ formation could be pro-
moted. In such experiments, it may be important toconsider crosstalk among media components in the
optimization of HBMEC/ciβ culture method, because
our results show that cbR apparently counteracts HC’s
effects, even though the mechanism behind this observa-
tion is currently unclear.
Enhanced barrier tightness, AJ formation, spindle-like
cell morphology, and abundant endothelial marker gene
expression, are all signs of endothelial differentiation. In
particular, AJ formation is critically important in not
Furihata et al. Fluids and Barriers of the CNS  (2015) 12:7 Page 13 of 15only stabilizing intercellular adhesion but also in pro-
moting endothelial differentiation [15,22]. On the other
hand, our results also show that cell migration is signifi-
cantly disturbed by HC when it is associated with a
reduction of MMP-2 and MMP-16 mRNA levels. In line
with the reversed characteristics observed in HBMEC/
ciβ cultured without HC (CSC-cbR or CSC-free), we
suggest taking a comprehensive view of the phenotype
transition; specifically, the mesenchymal-to-endothelial
transition (MEndT), into consideration in order to gain
a global picture of HC effects on HBMEC/ciβ. Recently,
it has become evident that the plasticity of endothelial
cells allows them to change their phenotype from endo-
thelial to mesenchymal, and vice versa, which are regarded
as the endothelial-to-mesenchymal transition (EndMT)
and the MEndT, respectively [36]. EndMT molecular
events are apparently similar to those of epithelial-to-
mesenchymal transition (EMT) in epithelial cells, which
includes abnormal intercellular junction formation,
extensive cell migration, and remarkable expression of
matrix remodeling genes [37]. Similarly, the reverse pro-
cesses, the MEndT and the mesenchymal-to-epithelial
transition (MET), appear to share numerous hallmarks,
such as cell-to-cell junction stabilization, actin filament
reorganization to the peri-plasma membrane region,
cell migration ability retardation, and an increase in
marker gene expression [37]. From this viewpoint, the
overall effects of HC on HBMEC/ciβ appear to be
closely related to MEndT. This is also consistent with
previous results showing that glucocorticoid induces
the MET or prevents the EMT in several cell types
[38-40]. However, alterations in mRNA expression of some
representative mesenchymal genes (such as α-smooth
muscle actin) were not associated with phenotype tran-
sition in our cells (data not shown). Taken together, it
appears that the effects of HC on HBMEC/ciβ can be
regarded as “MEndT-like”. When this view is applied to
the interpretations of previous literature, it appears that
MEndT-like glucocorticoid effects have also been found
in rat and mouse BMEC lines [41-43].
Because the MEndT/MET is a drastic phenotypic tran-
sition, it is not surprising that re-organization of various
cellular processes are involved during the MEndT-like
transition of HBMEC/ciβ. The present study, for the first
time, verified that increased ePE levels are one of those
processes. Although there have been no reports associat-
ing altered ePE levels with the MEndT/EndMT process,
it has been reported that primary bovine aortic endothe-
lial cells at the confluent state contain higher ePE levels
than at the sub-confluent state [44], and that increased
ePE levels were observed during the MET in MDCK
cells [45]. Thus, our results may share similar findings
with those reports. The ePE species identified here,
18:0p/20:4 PE and 16:0p/20:4 PE are classified asplasmalogens, and recent reports have shown that plas-
malogens have diverse biological activities [46]. Among
them, effects reducing membrane fluidity might be, at
least partially, involved in lowering Na-F permeability
and/or retarding mobility in HBMEC/ciβ cultured in
CSC-HC. Nevertheless, it remains mostly unclear whether
increased plasmalogen levels are adapted responses to
(and/or necessary for) the HC-mediated MEndT-like
process of HBMEC/ciβ. Therefore, progress in this new
area of study has the potential to allow us to advance
towards a greater understanding of a previously un-
acknowledged aspect of BBB biology and/or its barrier
property.
Finally, the mechanisms by which an HC-GR-pathway
facilitates AJ formation should be discussed. Based on
our results, it appears that the EPAC-RAP1 pathway is a
pivotal player involved in HC-mediated AJ protein trans-
location to the action site. Although it has been shown
that the pathway is critically involved in AJ formation
[21], our results are (to our knowledge) the first showing
that the EPAC-RAP1 pathway can be located down-
stream of the HC-GR signaling pathway.
Considering that GR is a transcription factor, it is rea-
sonable to assume that GR activation enhances EPAC
and RAP1 mRNA levels in order to expand their poten-
tial activity upon stimulation, but it is difficult to believe
that the GR function directly activates the EPAC-RAP1
activity. Rather, activated GR is likely to enhance or
repress target gene expression, which in turn elicits
various signals necessary to increase intracellular cAMP
levels leading to EPAC-RAP1 pathway activation. Al-
though it remains unknown what signaling pathways are
activated by HC in order to stimulate an increase in cel-
lular cAMP levels, we have observed that the expression
levels of various transcription and autocrine/paracrine
factors were targets of the HC-GR axis, as can be seen in
the representative results (see Additional file 7: Figure S5).
Therefore, it can be speculated that at least one of the
targets might be involved in the intermediate signaling
pathway(s) that bridge the gap between the HC-GR and
EPAC-RAP1 pathways. Identifying the target(s) involved
and the related signaling pathway(s) will be an interest-
ing and important challenge in future studies, not only
of HBMEC/ciβ but also of other BBB cells/cell lines.
Conclusions
Our results show that HC clearly improves HBMEC/ciβ
barrier functionality through GR activation, thus leading
to our recommendation that HC be regarded as an essen-
tial media component for HBMEC/ciβ-based in vitro BBB
models. It is also considered likely that these HC effects
result from the orchestration of diverse cellular signaling
networks, including those involved in modulating plasma-
logen levels and accelerating AJ formation, which appears
Furihata et al. Fluids and Barriers of the CNS  (2015) 12:7 Page 14 of 15to be adapted to (and/or lead to) MEndT-like phenotype
transitions. Nevertheless, since HBMEC/ciβ differenti-
ation status, including TJ formation, is likely to be fur-
ther promoted by optimization of culture conditions,
we hope that such research efforts will result in the
development of unique and useful HBMEC/ciβ-based
in vitro BBB models, while simultaneously providing
new opportunities to explore molecular events related
to MEndT/EndMT in BMEC.
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Additional file 1: Figure S1. Illustration of experimental procedure and
medium information. Culture schedules are shown at the top. At Day 3,
CSC-cbR was changed to fresh CSC-cbR, CSC-HC, or CSC-free medium, as
indicated at the center of the illustration. All functional analyses, including
immunocytochemistry, gene expression analyses, and Na-F permeability
assays, were performed at Day 12. Medium composition is shown at the
bottom.
Additional file 2: Table S1. Primers used for qPCR in this study.
Additional file 3: Table S2. Summary of identification of ether-
phosphatidylethanolamine molecules (PC, ePC, PE, ePE and SM) in
HBMEC/ciβ cells.
Additional file 4: Figure S2. Exploration of cooperative effects of
other SQs component(s) with hydrocortisone on barrier property of
HBMEC/ciβ. CSC-HC supplemented with ascorbate and heparin, which
are components of SQs, was used as a basic medium. Different SQs
growth factor combinations were tested to determine if they had the
potential to further enhance HBMEC/ciβ barrier properties. The “-” and
“+” symbols indicate absence and presence of respective growth factors.
Three days after cell seeding, the medium was changed to one of the
two above-mentioned media. The cells were continuously cultured for
12 days, after which Na-F permeability assay was performed. The Papp
value obtained from the cells cultured with CSC-HC in the absence of
any growth factors was set to the basal level (=1) in each assay. Each
bar represents the mean ± S.D. of the relative Na-F permeability values,
which were obtained from three independent experiments.
Additional file 5: Figure S3. VE-cadherin expression profile in HBMEC/ciβ.
A, VE-cadherin mRNA expression in HBMEC/ciβ cultured with CSC-cbR or
CSC-HC were determined by real-time PCR. Each value represents mean ± S.
D. of three independent assays, each performed in duplicate. The mean value
obtained from HBMEC/ciβ cultured with CSC-cbR was set to 1. B, VE-cadherin
protein expressions in HBMEC/ciβ cultured with CSC-cbR or CSC-HC was
determined by Western blot. β-actin protein expression was used as a
loading control. The representative results of three independent assays
are shown.
Additional file 6: Figure S4. Claudin-5 and occludin expression profiles
in HBMEC/ciβ. A, claudin-5 and occludin mRNA expressions in HBMEC/ciβ
cultured with CSC-cbR or CSC-HC were determined by real-time PCR.
Each value represents mean ± S.D. of three independent assays, each
performed in duplicate. The mean value obtained from HBMEC/ciβ cultured
with CSC-cbR was set as 1. B, claudin-5 and occludin protein expression in
HBMEC/ciβ cultured with CSC-cbR or CSC-HC was determined by Western
blot. β-actin protein expression was used as a loading control. The
representative results of three independent assays are shown.
Additional file 7: Figure S5. ANGPT2, Id-1, Egr-1 and HDAC7 mRNA
expression in HBMEC/ciβ cultured with CSC-cbR, CSC-free, or CSC-HC.
ANGPT2, Id-1, Egr-1 and HDAC7 mRNA expression levels in cells cultured
with CSC-cbR, CSC-free, or CSC-HC, were examined by qPCR. The effect
of a GR antagonist, RU486, on HC-mediated modulation of mRNA expression
was also investigated. mRNA expression levels were calculated relative
to the value obtained from CSC-cbR cells (set as basal level =1). Each
value in the above experiments is expressed as mean ± S.D. obtained
from three independent experiments. The “-” symbol indicates that
DMSO (0.1%) was added to the medium as a control. The single anddouble asterisks indicate p < 0.05 and p < 0.01, respectively, compared
with the value of CSC-free. ANGPT2 is a secreted glycoprotein member
of the angiopoietin family of growth factors. It has been shown to
be involved in functional impairment of the BBB [47]. Id-1 is a basic
helix-loop-helix transcription factor family member, while lacking a
basic DNA binding domain. It has been shown that Id-1 plays a facilitative
role in EMT [48]. EGR-1 is a C2H2-class zinc finger transcription factor and its
knockdown has been shown to be associated with retardation of cell
migration ability [49]. HDAC7 is a member of the HDACs that contribute
to gene transcription control via modification of acetylation level of
histones, along with other proteins. It has been reported that HDAC7
mRNA knockdown causes reduction of endothelial migration [50].
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